Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioGaia AB (publ)

BGLAF
Current price
10.5 USD 0 USD (0.00%)
Last closed 107.4 SEK
ISIN SE0017769995
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange ST
Capitalization 10 962 955 239 SEK
Yield for 12 month +1.24 %
1Y
3Y
5Y
10Y
15Y
BGLAF
21.11.2021 - 28.11.2021

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden. Address: Kungsbroplan 3, Stockholm, Sweden, 112 27

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 747.42 SEK

P/E ratio

32.2755

Dividend Yield

1.78 %

Current Year

+1 303 364 788 SEK

Last Year

+1 109 798 167 SEK

Current Quarter

+305 579 070 SEK

Last Quarter

+386 154 088 SEK

Current Year

+955 216 707 SEK

Last Year

+806 172 375 SEK

Current Quarter

+223 511 199 SEK

Last Quarter

+285 543 634 SEK

Key Figures BGLAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 475 591 733 SEK
Operating Margin TTM 32.04 %
PE Ratio 32.2755
Return On Assets TTM 13.62 %
PEG Ratio
Return On Equity TTM 18.69 %
Wall Street Target Price 1 747.42 SEK
Revenue TTM 1 362 834 715 SEK
Book Value 16.1 SEK
Revenue Per Share TTM
Dividend Share 1.91 SEK
Quarterly Revenue Growth YOY -4.3 %
Dividend Yield 1.78 %
Gross Profit TTM 806 171 371 SEK
Earnings per share 3.36 SEK
Diluted Eps TTM 3.36 SEK
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -64.2 %
Profit Margin 24.85 %

Dividend Analytics BGLAF

Dividend growth over 5 years

68 %

Continuous growth

2 years

Payout Ratio 5 years average

34 %

Dividend History BGLAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.9
Ex Dividend Date 08.05.2024
Forward Annual Dividend Yield 1.77 %
Last Split Factor 5:1
Payout Ratio 56.89 %
Last Split Date 18.05.2022
Dividend Date

Stock Valuation BGLAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 32.2755
Forward PE
Enterprise Value Revenue 7.1922
Price Sales TTM 8.0442
Enterprise Value EBITDA 19.0599
Price Book MRQ 6.7075

Financials BGLAF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BGLAF

For 52 weeks

95.08 SEK 137.32 SEK
50 Day MA 111.29 SEK
Shares Short Prior Month
200 Day MA 120.95 SEK
Short Ratio
Shares Short
Short Percent